Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 9Neoplasms 6Anxiety Disorders 6Head and Neck Neoplasms 3Depression 3Hot Flashes 2Chronic Pain 2Xerostomia 1Vomiting 1Uterine Cervical Neoplasms 1Tendinopathy 1Smoking Cessation 1Sleep Wake Disorders 1Radiculopathy 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Pathophobia 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Nociceptive Pain 1Neuralgia, Postherpetic 1Neuralgia 1Nausea 1Myocarditis 1Musculoskeletal Pain 1Melanoma 1Medication Adherence 1Lung Diseases, Interstitial 1Leukemia, Myeloid, Acute 1

Interventions

Standard of Care 3Self-Management 1Pharmacists 1Pharmaceutical Services 1Palliative Care 1Motivational Interviewing 1Hypnosis 1Historically Controlled Study 1General Practitioners 1Drug Delivery Systems 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Medication Adherence × Hypnosis × Clear all
NCT02657993 2021-06-22

Hypnosis to Reduce Aromatase Inhibitor Pain and Improve Adherence

Icahn School of Medicine at Mount Sinai

Phase NA Completed
191 enrolled
Breast

Breast Neoplasms, Medication Adherence, Musculoskeletal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡